First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis

Area of Science:

• Pulmonary Medicine
• Pharmacotherapy
• Real-world Evidence

Background:

• Clinical guidelines advocate long-acting bronchodilators for initial chronic obstructive pulmonary disease (COPD) maintenance therapy.
• Inhaled corticosteroids (ICS) are recommended for severe COPD or frequent exacerbations.

Purpose of the Study:

• To investigate real-world prescribing patterns of first maintenance therapy for COPD in the UK.
• To compare prescribing practices against current clinical guidelines.

Main Methods:

• Analysis of UK Optimum Patient Care Research Database data from 2009-2012.
• Inclusion of patients with a new COPD maintenance therapy prescription and prior COPD diagnosis.
• Characterization of patients based on demographics, disease history, symptoms, comorbidities, and treatment, stratified by disease severity and GOLD group (A-D).

Main Results:

• Long-acting muscarinic antagonists (LAMAs) were prescribed as monotherapy for 40.2% of patients.
• ICS, alone or in combination, were prescribed to over 40% of patients across all GOLD groups.
• ICS-containing regimens were given to patients with comorbidities and pneumonia history, where risks might exceed benefits.

Conclusions:

• Real-world prescribing shows ICS are often used outside guideline recommendations for newly diagnosed COPD patients in the UK.
• LAMAs are increasingly prescribed as first maintenance therapy, aligning better with guideline recommendations.